Page last updated: 2024-10-26

enoxacin and Dengue

enoxacin has been researched along with Dengue in 1 studies

Enoxacin: A broad-spectrum 6-fluoronaphthyridinone antibacterial agent that is structurally related to NALIDIXIC ACID.
enoxacin : A 1,8-naphthyridine derivative that is 1,4-dihydro-1,8-naphthyridine with an ethyl group at the 1 position, a carboxy group at the 3-position, an oxo sustituent at the 4-position, a fluoro substituent at the 5-position and a piperazin-1-yl group at the 7 position. An antibacterial, it is used in the treatment of urinary-tract infections and gonorrhoea.

Dengue: An acute febrile disease transmitted by the bite of AEDES mosquitoes infected with DENGUE VIRUS. It is self-limiting and characterized by fever, myalgia, headache, and rash. SEVERE DENGUE is a more virulent form of dengue.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Scroggs, SLP1
Gass, JT1
Chinnasamy, R1
Widen, SG1
Azar, SR1
Rossi, SL1
Arterburn, JB1
Vasilakis, N1
Hanley, KA1

Other Studies

1 other study available for enoxacin and Dengue

ArticleYear
Evolution of resistance to fluoroquinolones by dengue virus serotype 4 provides insight into mechanism of action and consequences for viral fitness.
    Virology, 2021, 01-02, Volume: 552

    Topics: Adaptation, Biological; Animals; Antiviral Agents; Biological Evolution; Cell Line; Chlorocebus aeth

2021